+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
BioCryst Pharmaceuticals Inc - logo

BioCryst Pharmaceuticals is a biotechnology company that designs and develops small molecule drugs that block key enzymes involved in the pathogenesis of diseases. BioCryst's core development programs include BCX7353 and additional 2nd generation oral inhibitors of plasma kallikrein for hereditary angioedema; and BCX4430 (GALIDESIVIR), a broad spectrum antiviral for hemorrhagic fevers. The company was founded in 1986 and is headquartered in Durham, North Carolina.

From
Market Spotlight: Zika virus - Product Thumbnail Image

Market Spotlight: Zika virus

  • Report
  • February 2021
  • 24 Pages
  • Global
Licensing Deals in Pharmaceuticals 2019-2024 - Product Thumbnail Image

Licensing Deals in Pharmaceuticals 2019-2024

  • Report
  • March 2024
  • 1300 Pages
  • Global
From
T-Cell Leukemia Global Clinical Trials Review, H2, 2019 - Product Thumbnail Image

T-Cell Leukemia Global Clinical Trials Review, H2, 2019

  • Clinical Trials
  • December 2019
  • 221 Pages
  • Global
From
Yellow Fever - Pipeline Review, H2 2020 - Product Thumbnail Image

Yellow Fever - Pipeline Review, H2 2020

  • Drug Pipelines
  • October 2020
  • 71 Pages
  • Global
From
Marburgvirus Infections (Marburg Hemorrhagic Fever) - Pipeline Review, H2 2020 - Product Thumbnail Image

Marburgvirus Infections (Marburg Hemorrhagic Fever) - Pipeline Review, H2 2020

  • Drug Pipelines
  • September 2020
  • 112 Pages
  • Global
From
Ebolavirus Infections (Ebola Hemorrhagic Fever) - Pipeline Review, H2 2020 - Product Thumbnail Image

Ebolavirus Infections (Ebola Hemorrhagic Fever) - Pipeline Review, H2 2020

  • Drug Pipelines
  • September 2020
  • 342 Pages
  • Global
From
Zika Virus Infections - Pipeline Review, H1 2020 - Product Thumbnail Image

Zika Virus Infections - Pipeline Review, H1 2020

  • Drug Pipelines
  • June 2020
  • 274 Pages
  • Global
From
From
Loading Indicator